N. Saleem Basha, Kewani Ghirmay and Melles Kahsase. In silico comparison of interleukin-2 of Homo sapiens with different species. Pharma Focus: The journal of Eritrean Pharmaceutical Association (ERIPA), Vol. 14, Dec 10 2011, pp32-37. (original) (raw)

Interleukin-2: A major lymphokine

Diane Komp

The Journal of Pediatrics, 1989

View PDFchevron_right

Distinct Clinical and Laboratory Activity of Two Recombinant Interleukin-2 Preparations

Jacquelyn Hank

Clinical Cancer Research, 1999

View PDFchevron_right

Human Interleukin 2 (IL-2) Promotion of Immune Regulation and ClinicalOutcomes: A Review

Claudia Regina Bonini Domingos

Journal of Cytokine Biology, 2016

View PDFchevron_right

Efficacy and antitumor activity of a mutant type of interleukin 2

amir amanzadeh

Scientific Reports

View PDFchevron_right

In Vivo Effects of Recombinant Human Interleukin 2 on Antitumor and Antiviral Natural Immunity in Induced or Natural Murine Immunodeficiency States

Larry Bobbitt

View PDFchevron_right

Interleukin-2 and cancer: Critical analysis of results, problems and expectations

abdelkrim alileche

View PDFchevron_right

Induction of High-Affinity Interleukin 2 Receptors on Human T Lymphocytes

Carsten Larsen

Scandinavian Journal of Immunology, 1989

View PDFchevron_right

Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. Cancer Res 47: 5725-5732

James E Talmadge

Cancer Research

View PDFchevron_right

A qualitative difference in the interleukin 2 (IL-2) requirement of helper and cytotoxic T lymphocytes

Raymond Kaempfer

Cellular Immunology, 1984

View PDFchevron_right

Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease

James E Talmadge

Cancer Research, 1987

View PDFchevron_right

Interleukin-2 as immunotherapeutic in the autoimmune diseases

M. A . Stephano

International Immunopharmacology, 2020

View PDFchevron_right

The Interleukin-2 Receptor: A Target for Immunotherapy

Jeffrey White

Annals of the New York Academy of Sciences, 1993

View PDFchevron_right

Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: Contribution of large granular lymphocytes and T lymphocytes

James E Talmadge

Cellular Immunology, 1986

View PDFchevron_right

Interleukin2 and cancer

abdelkrim alileche

Medical Hypotheses, 2003

View PDFchevron_right

Antibodies of Predetermined Specificity against Chemically Synthesized Peptides of Human Interleukin 2

Jose Luis Cardenas

Proceedings of The National Academy of Sciences, 1984

View PDFchevron_right

The Human Interleukin2 Receptor: Analysis of Structure and Function

joel depper

Immunological Reviews, 1986

View PDFchevron_right

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin

Sandra Cardona

British Journal of Haematology, 1990

View PDFchevron_right

Interleukin 2 (IL2) Augments Transcription of the IL2 Receptor Gene

joel depper

Proceedings of The National Academy of Sciences, 1985

View PDFchevron_right

Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones

Marcelo Sztein

Proceedings of the National Academy of Sciences of the United States of America, 1986

View PDFchevron_right

Purification of interleukin-2 antibodies from healthy individuals

Maria Luisa Villa

Immunology Letters, 1993

View PDFchevron_right

A simple and sensitive bioassay for the detection of IL-2 activity

Gustav Gaudernack

Journal of Immunological Methods, 1988

View PDFchevron_right

Molecular Cloning of cDNA for the Human Interleukin2 Receptor

joel depper

View PDFchevron_right

Interleukin 2 receptor gene expression in normal human T lymphocytes

joel depper

Proceedings of the National Academy of Sciences of the United States of America, 1985

View PDFchevron_right

Cancer, cytokines, and cytotoxic cells: Interleukin-2 in the immunotherapy of human neoplasms

J. Atzpodien

Klinische Wochenschrift, 1990

View PDFchevron_right

The Human Interleukin-2 Receptor

joel depper

Journal of Cell Science, 1985

View PDFchevron_right

Bosco, M. C. et al. Regulation by interleukin-2 (IL-2) and interferon of IL-2 receptor chain gene expression in human monocytes. Blood 83, 2995-3002

Dan Longo

Blood

View PDFchevron_right

Differential effects of interleukin-2 blockade on apoptosis in na??ve and activated human lymphocytes12

John Daller

Transplantation, 2003

View PDFchevron_right

Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression

Khaled Saraya

British Journal of Cancer, 1993

View PDFchevron_right

Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status

Graham Pawelec

1991

View PDFchevron_right

Interleukin-2 and human monocyte activation

Luigi Varesio

Journal of leukocyte biology, 1995

View PDFchevron_right